Results 41 to 50 of about 25,184 (290)

Nucleotide analogue inhibitors of purine nucleoside phosphorylase.

open access: hybridJournal of Biological Chemistry, 1990
The diphosphate of the antiherpetic agent acyclovir [9-[(2-hydroxyethoxy)methyl]guanine] has been shown to inhibit purine nucleoside phosphorylase with unique potency (Tuttle, J. V., and Krenitsky, T. A. (1984) J. Biol. Chem. 259, 4065-4069). A major factor contributing to the superior inhibition by this diphosphate over the corresponding mono- and ...
Thomas A. Krenitsky   +5 more
openalex   +4 more sources

Purine nucleoside phosphorylase targeted by annexin v to breast cancer vasculature for enzyme prodrug therapy. [PDF]

open access: yesPLoS ONE, 2013
BACKGROUND AND PURPOSE: The targeting of therapeutics is a promising approach for the development of new cancer treatments that seek to reduce the devastating side effects caused by the systemic administration of current drugs.
John J Krais   +2 more
doaj   +2 more sources

Purine nucleoside phosphorylase deficiency in two unrelated Saudi patients

open access: diamondAnnals of Saudi Medicine, 2009
Purine nucleoside phosphorylase (PNP) deficiency is a rare autosomal recessive metabolic disorder that results in combined immunodeficiency, neurologic dysfunction and autoimmunity.
Alangari Abdullah   +4 more
doaj   +2 more sources

Cerebellar abnormalities in purine nucleoside phosphorylase deficient mice

open access: yesNeurobiology of Disease, 2012
Inherited defects in purine nucleoside phosphorylase (PNP) cause severe T cell immunodeficiency and progressive neurological dysfunction, yet little is known about the effects of PNP deficiency on the brain.
Alireza Mansouri   +9 more
doaj   +4 more sources

Metabolites of purine nucleoside phosphorylase (NP) in serum have the potential to delineate pancreatic adenocarcinoma. [PDF]

open access: yesPLoS ONE, 2011
Pancreatic Adenocarcinoma (PDAC), the fourth highest cause of cancer related deaths in the United States, has the most aggressive presentation resulting in a very short median survival time for the affected patients. Early detection of PDAC is confounded
Shaiju K Vareed   +19 more
doaj   +5 more sources

8‐Aminoguanine Induces Diuresis, Natriuresis, and Glucosuria by Inhibiting Purine Nucleoside Phosphorylase and Reduces Potassium Excretion by Inhibiting Rac1 [PDF]

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background 8‐Aminoguanosine and 8‐aminoguanine are K+‐sparing natriuretics that increase glucose excretion. Most effects of 8‐aminoguanosine are due to its metabolism to 8‐aminoguanine.
Edwin K. Jackson   +3 more
doaj   +2 more sources

Genetic resistance to purine nucleoside phosphorylase inhibition in Plasmodium falciparum. [PDF]

open access: yesProc Natl Acad Sci U S A, 2018
Ducati RG   +6 more
europepmc   +2 more sources

Cloning and expression of recombinant purine nucleoside phosphorylase in the methylotrophic yeast Pichia pastoris

open access: yesJournal of Advanced Biotechnology and Experimental Therapeutics, 2023
Purine Nucleoside Phosphorylase (PNP) is an enzyme involved in biosynthetic pathway of purine nucleosides. Purine nucleoside phosphorylase catalyzes the cleavage of the glycosidic bond of ribo- or deoxyribonucleosides to form the purine base and ...
Jaloliddin Abdurakhmanov   +12 more
doaj   +1 more source

Home - About - Disclaimer - Privacy